British Journal of Cancer - Table of Contents alert Volume 114 Issue 7

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 114, Issue 7 (713-848) Published online 29 March 2016 In this issue Editorial Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top PARP inhibitors: the race is on Jessica S Brown, Stan B Kaye and Timothy A Yap Br J Cancer 2016 114: 713-715; 10.1038/bjc.2016.67 Full Text Minireview Top From obesity to diabetes and cancer: epidemiological links and role of therapies Custodia García-Jiménez, María Gutiérrez-Salmerón, Ana Chocarro-Calvo, Jose Manuel García-Martinez, Angel Castaño and Antonio De la Vieja Br J Cancer 2016 114: 716-722; advance online publication, February 23, 2016; 10.1038/bjc.2016.37 Abstract | Full Text Clinical Studies Top Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer Yvette Drew, Jonathan Ledermann, Geoff Hall, Daniel Rea, Ros Glasspool, Martin Highley, Gordon Jayson, Julieann Sludden, James Murray, David Jamieson, Sarah Halford, Gary Acton, Zoe Backholer, Raffaella Mangano, Alan Boddy, Nicola Curtin and Ruth Plummer Br J Cancer 2016 114: 723-730; advance online publication, March 22, 2016; 10.1038/bjc.2016.41 Abstract | Full Text The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study Anna Kuchel, Tim Robinson, Charles Comins, Mike Shere, Mohini Varughese, Geoff Sparrow, Ajay Sahu, Louise Saunders, Amit Bahl, Simon J Cawthorn and Jeremy P Braybrooke Br J Cancer 2016 114: 731-736; advance online publication, March 8, 2016; 10.1038/bjc.2016.48 Abstract | Full Text Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade Hidenori Toyoda, Paul BS Lai, James O'Beirne, Charing C Chong, Sarah Berhane, Helen Reeves, Derek Manas, Richard P Fox, Winnie Yeo, Frankie Mo, Anthony WH Chan, Toshifumi Tada, Mercedes Iñarrairaegui, Arndt Vogel, Nora Schweitzer, Stephen L Chan, Bruno Sangro, Takashi Kumada and Philip J Johnson Br J Cancer 2016 114: 744-750; 10.1038/bjc.2016.33 Abstract | Full Text Use of a 12 months’ self-referral reminder to facilitate uptake of bowel scope (flexible sigmoidoscopy) screening in previous non-responders: a London-based feasibility study Robert S Kerrison, Lesley M McGregor, Sarah Marshall, John Isitt, Nicholas Counsell, Jane Wardle and Christian von Wagner Br J Cancer 2016 114: 751-758; advance online publication, March 15, 2016; 10.1038/bjc.2016.43 Abstract | Full Text Translational Therapeutics Top Hexokinase 2 is a determinant of neuroblastoma metastasis Liat Edry Botzer, Shelly Maman, Orit Sagi-Assif, Tsipi Meshel, Ido Nevo, Ilana Yron and Isaac P Witz Br J Cancer 2016 114: 759-766; advance online publication, March 17, 2016; 10.1038/bjc.2016.26 Abstract | Full Text Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection Yi-Peng Fu, Yong Yi, Xiao-Yan Cai, Jian Sun, Xiao-Chun Ni, Hong-Wei He, Jia-Xing Wang, Zhu-Feng Lu, Jin-Long Huang, Ya Cao, Jian Zhou, Jia Fan and Shuang-Jian Qiu Br J Cancer 2016 114: 767-776; advance online publication, March 22, 2016; 10.1038/bjc.2016.47 Abstract | Full Text Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair Elena S Ratner, Yong-Lian Zhu, Philip G Penketh, Julie Berenblum, Margaret E Whicker, Pamela H Huang, Yashang Lee, Kimiko Ishiguro, Rui Zhu, Alan C Sartorelli and Z Ping Lin Br J Cancer 2016 114: 777-786; advance online publication, March 10, 2016; 10.1038/bjc.2016.54 Abstract | Full Text A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer Anita Annaházi, Szabolcs Ábrahám, Klaudia Farkas, András Rosztóczy, Orsolya Inczefi, Imre Földesi, Mónika Szűcs, Mariann Rutka, Vassilia Theodorou, Helene Eutamene, Lionel Bueno, György Lázár, Tibor Wittmann, Tamás Molnár and Richárd Róka Br J Cancer 2016 114: 787-792; advance online publication, February 23, 2016; 10.1038/bjc.2016.31 Abstract | Full Text Molecular Diagnostics Top Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes A H Thomson, J McGrane, J Mathew, J Palmer, D A Hilton, G Purvis and R Jenkins Br J Cancer 2016 114: 793-800; advance online publication, February 23, 2016; 10.1038/bjc.2016.34 Abstract | Full Text BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival Emilia Hugdahl, May Britt Kalvenes, Hanne E Puntervoll, Rita G Ladstein and Lars A Akslen Br J Cancer 2016 114: 801-808; advance online publication, February 25, 2016; 10.1038/bjc.2016.44 Abstract | Full Text Clinical Studies Top Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer Stacey M Stein, Edward S James, Yanhong Deng, Xiangyu Cong, Jeremy S Kortmansky, Jia Li, Carol Staugaard, Doddamane Indukala, Ann Marie Boustani, Vatsal Patel, Charles H Cha, Ronald R Salem, Bryan Chang, Howard S Hochster and Jill Lacy Br J Cancer 2016 114: 809-812; 10.1038/bjc.2016.45 Abstract | Full Text Epidemiology Top Long-term impact of preeclampsia on maternal endometrial cancer risk Sara Hallum, Anja Pinborg and Mads Kamper-Jørgensen Br J Cancer 2016 114: 809-812; advance online publication, March 10, 2016; 10.1038/bjc.2016.55 Abstract | Full Text Long working hours and cancer risk: a multi-cohort study Katriina Heikkila, Solja T Nyberg, Ida E H Madsen, Ernest de Vroome, Lars Alfredsson, Jacob J Bjorner, Marianne Borritz, Hermann Burr, Raimund Erbel, Jane E Ferrie, Eleonor I Fransson, Goedele A Geuskens, Wendela E Hooftman, Irene L Houtman, Karl-Heinz Jöckel, Anders Knutsson, Markku Koskenvuo, Thorsten Lunau, Martin L Nielsen, Maria Nordin, Tuula Oksanen, Jan H Pejtersen, Jaana Pentti, Martin J Shipley, Andrew Steptoe, Sakari B Suominen, Töres Theorell, Jussi Vahtera, Peter J M Westerholm, Hugo Westerlund, Nico Dragano, Reiner Rugulies, Ichiro Kawachi, G David Batty, Archana Singh-Manoux, Marianna Virtanen and Mika Kivimäki for the IPD-Work Consortium Br J Cancer 2016 114: 813-818; advance online publication, February 18, 2016; 10.1038/bjc.2016.9 Abstract | Full Text Analgesic medication use and risk of epithelial ovarian cancer in African American women Lauren C Peres, Fabian Camacho, Sarah E Abbott, Anthony J Alberg, Elisa V Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L Cote, Sydnee Crankshaw, Ellen Funkhouser, Patricia G Moorman, Edward S Peters, Ann G Schwartz, Paul Terry, Frances Wang and Joellen M Schildkraut Br J Cancer 2016 114: 819-825; advance online publication, February 23, 2016; 10.1038/bjc.2016.39 Abstract | Full Text Relationship between ambient ultraviolet radiation and Hodgkin lymphoma subtypes in the United States Emily M Bowen, Ruth M Pfeiffer, Martha S Linet, Wayne T Liu, Dennis D Weisenburger, D Michal Freedman and Elizabeth K Cahoon Br J Cancer 2016 114: 826-831; advance online publication, February 18, 2016; 10.1038/bjc.2015.383 Abstract | Full Text Previous tonsillectomy modifies odds of tonsil and base of tongue cancer Jose P Zevallos, Angela L Mazul, Nidia Rodriguez, Mark C Weissler, Paul Brennan, Devasena Anantharaman, Behnoush Abedi-Ardekani, D Neil Hayes and Andrew F Olshan Br J Cancer 2016 114: 832-838; advance online publication, March 15, 2016; 10.1038/bjc.2016.63 Abstract | Full Text Is birthweight associated with total and aggressive/lethal prostate cancer risks? A systematic review and meta-analysis Cindy Ke Zhou, Siobhan Sutcliffe, Judith Welsh, Karen Mackinnon, Diana Kuh, Rebecca Hardy and Michael B Cook Br J Cancer 2016 114: 839-848; advance online publication, March 1, 2016; 10.1038/bjc.2016.38 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.